uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Prevalence of violence exposure in women with premenstrual dysphoric disorder in comparison with other gynecological patients and asymptomatic controls
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health. (Reproduktiv hälsa/Sundström Poromaa)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health. (Reproduktiv hälsa/Sundström Poromaa)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health. (Reproduktiv hälsa/Sundström Poromaa)
Department of Clinical Science, Obstetrics and Gynecology, Umeå University, Umeå, Sweden..
Show others and affiliations
2011 (English)In: Acta Obstetricia et Gynecologica Scandinavica, ISSN 0001-6349, E-ISSN 1600-0412, Vol. 90, no 7, 746-752 p.Article in journal (Refereed) Published
Abstract [en]

Objective. The aim of the present study was to estimate prevalence rates of physical,emotional and sexual abuse in women with premenstrual dysphoric disorder(PMDD) in comparison with gynecological outpatients and asymptomatic healthycontrol subjects. Design. Cross-sectional study. Settings. Departments of obstetricsand gynecology in three different Swedish hospitals. Population. Fifty-eightwomen meeting strict criteria for PMDD, a control group of 102 women seekingcare at the gynecological outpatient clinic (ObGyn controls) and 47 asymptomatichealthy control subjects were included in this study. Methods. The Swedish versionof the Abuse Assessment Screen was used to collect information on physical andsexual abuse, and the screening instrument was administered as a face-to-face interview.Main Outcome Measures. Previous and ongoing physical and sexual abuse.Results. Any lifetime abuse (physical, emotional or sexual) was reported by 31.0%of PMDD patients, by 39.2% of ObGyn controls and by 21.3% of healthy controls.The ObGyn controls reported physical and/or emotional abuse significantly moreoften than PMDD patients as well as healthy controls (p<0.05). Lifetime sexualabuse was reported significantly more often by ObGyn controls than by healthycontrols (p<0.05). Conclusions. Patients with PMDD appear not to have sufferedphysical, emotional or sexual abuse to a greater extent than other gynecologicalpatients or healthy control subjects. However, exposure to violence was common inall groups of interviewed women, and for the individual patient these experiencesmay contribute to their experience of symptoms.

Place, publisher, year, edition, pages
2011. Vol. 90, no 7, 746-752 p.
Keyword [en]
physical abuse, emotional abuse, sexual abuse, premenstrual dysphoric disorder
National Category
Obstetrics, Gynecology and Reproductive Medicine
Research subject
Medical Science
Identifiers
URN: urn:nbn:se:uu:diva-145183DOI: 10.1111/j.1600-0412.2011.01151.xISI: 000292436500009OAI: oai:DiVA.org:uu-145183DiVA: diva2:396027
Available from: 2011-02-08 Created: 2011-02-07 Last updated: 2017-12-11Bibliographically approved
In thesis
1. Is it Just the Hormones?: Sex Steroids, Chronic Stress and Violence in Premenstrual Dysphoric Disorder
Open this publication in new window or tab >>Is it Just the Hormones?: Sex Steroids, Chronic Stress and Violence in Premenstrual Dysphoric Disorder
2011 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Premenstrual depressive symptoms and mood swings affect 3-8% of women in fertile age. The female hormones are believed to be the cause. Progesterone is well studied, but estrogen is not, and either are other causes such as intimate partner violence and chronic stress.

The aim in this thesis was to investigate the influence of hormones as well as psychological aspects on the most common problems among women seeking care for premenstrual symptoms.

In a cross-sectional study, four groups of women were included: ongoing users of oral contraceptives, with or without adverse mood symptoms and previous users, with or without experience of adverse mood. Depression and anxiety were significantly more common in both groups with reported adverse mood, in comparison with their control groups with no adverse mood. Self-reported PMS was significantly more common in those women who reported adverse mood, however, there was no difference in prospectively defined PMS or PMDD between the two groups of previous users.

In a RCT with 25 women completing the study, GnRH treatment were tested in combination with two different HRT add-back doses of estradiol, in combination with progesterone and placebo. The higher dose of estrogen 1.5 mg in combination with progesterone induced significantly more pronounced symptoms than in combination with placebo. The lower dose, 0.5 mg gave less symptom recurrence in combination with progesterone.

Exposure to violence was investigated among PMDD patients, healthy controls and gynecological patients. Among the participating women, gynecological patients, reported physical and/or emotional abuse significantly more often than did PMDD patients, as well as healthy controls.

Chronic stress was investigated with diurnal cortisol, and low-dose dexamethasone test.  There was no difference in diurnal secretion of cortisol between PMDD patients and controls. No difference in the degree of dexamethasone suppression was found between PMDD patients and controls.

According to the results from these studies, the main symptom provoking factor in women with PMDD appears to be the estradiol and progesterone fluctuations across the menstrual cycle, whereas chronic stress and intimate partner violence appears to be less relevant.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2011. 70 p.
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 642
Keyword
premenstrual dysphoric disorder; combined oral contraceptive; GnRH agonist; add-back; estradiol; progesterone; chronic stress; intimate partner violence; depression, anxiety; allopregnanolone
National Category
Obstetrics, Gynecology and Reproductive Medicine
Research subject
Obstetrics and Gynaecology
Identifiers
urn:nbn:se:uu:diva-145384 (URN)978-91-554-8004-2 (ISBN)
Public defence
2011-03-25, Rosénsalen, Akademiska Sjukhuset Ing 95/96, Uppsala, 13:00 (Swedish)
Opponent
Supervisors
Available from: 2011-03-04 Created: 2011-02-08 Last updated: 2011-05-04

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Segebladh, BirgittaBannbers, ElinKask, KristiinaHeimer, GunSundström-Poromaa, Inger

Search in DiVA

By author/editor
Segebladh, BirgittaBannbers, ElinKask, KristiinaHeimer, GunSundström-Poromaa, Inger
By organisation
Department of Women's and Children's HealthNational Centre for Knowledge on Men
In the same journal
Acta Obstetricia et Gynecologica Scandinavica
Obstetrics, Gynecology and Reproductive Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 479 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf